Bone Morphogenetic Protein Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Bone Morphogenetic Protein Market is Segmented by Type, Application (Spinal Fusion, Trauma, Reconstructive Surgery, Oral-maxillofacial), and Geography

Market Snapshot

bone morphogenetic protein market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 2.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The global bone morphogenetic protein market is expected to grow with a CAGR of 2.5% during the forecasted period. The key factors that are responsible for the growth of the market include the growth in the incidences of sports-related injuries, the growing demand for minimally invasive surgeries, and technological advancements that are being done in the field of the bone morphogenetic protein.

According to the Centre for Disease Control and Prevention, the number of people participating in sports is increasing across both developing and developed nations, and this is ultimately leading to an increased number of sports injuries. Approximately, 8.6 million individuals are getting injured during sports annually, as stated by the National Institute of Health (NIH), 2016. This accounts for 34.1 people per 1,000. Spinal injury is the most frequent injury that was seen among the injured population during NIH survey.

As the number of such sports-related injury is increasing, there is a growing demand for bone morphogenetic protein, as this protein helps people who need to obtain bone formation.

Scope of the Report

Bone morphogenetic proteins (BMPs) are signaling molecules and most are a part of the Transforming Growth Factor-β (TGFβ) family of proteins. BMPs have an important role in bone and cartilage formation, and embryogenesis. This report includes a detailed analysis of the types and applications of bone morphogenetic proteins. Bone Morphogenetic Protein Market is segmented By Type, By Application and Geography

Recombinant Human Bone Morphogenetic Protein (rhBMP) - 2
Recombinant Human Bone Morphogenetic Protein (rhBMP) -7
Spinal Fusion
Reconstructive Surgery
North America
United States
United Kingdom
Rest of Europe
South korea
Rest of Asia-Pacific
Middle East & Africa
South Africa
Rest of Middle East & Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Spinal Fusion is Expected to Hold the Highest Market Share in the Application Segment

In the application segment, spinal fusion is believed to have the largest market size. Bone morphogenetic protein (BMP) is a protein which stimulates the formation of bone in the body and it is widely used in the spinal fusion surgery. Studies have revealed that BMP is accepted widely to facilitate the fusion at the rate greater than that of traditional bone graft surgery. Due to this reason, BMP gives the surgeon the freedom to perform the surgery with the ease of the improved fusion rate, which avoids the complications of an iliac crest autograft (hip) graft harvest. When the hip graft is avoided, it shortens the amount of the time taken for surgery, and reduces complication rates, allowing for quicker and less painful recovery time. With the rise in the number of spinal surgeries and the ease of surgery with the help of BMP, its application is increasing rapidly in spinal fusion surgery.

Bone Protein Market Trend.png

North America Dominates the Market and Expected to do Same in the Forecast Period

North America currently dominates the market and is expected to continue its stronghold for a few more years. A well-established healthcare system and the adoption of novel technologies in the region are the prime factors responsible for the growth of the market in this region.

The US FDA approved the protein molecule called rhBMP-2 has become one of the preferred procedure for the surgeries associated with bone in the United States. As per the data published by National Spinal Cord Injury Statistical Center, 2019, approximately 17,730 cases of spinal cord injuries occur annually in the United States, which indicates that there is a great scope for the bone morphogenetic protein usage in the country.

Bone Morphogenetic Market - Growth Rate by Region

Competitive Landscape

The market is moderately competitive and consists of several companies. In terms of market share, a small number of major players currently dominate the market. However, with technological advancement and product innovation, mid-size to smaller companies are increasing their market presence by introducing new products at affordable prices. Companies like Medtronic Inc., Stryker Corporation, Thermo Fischer Scientific hold a substantial market share.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Incidences of Sports-related Injury

      2. 4.2.2 Rising Demand for Minimally Invasive Surgeries

      3. 4.2.3 Technological Advancements

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Procedure

      2. 4.3.2 Alternative Treatment Availability

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 Type

      1. 5.1.1 Recombinant Human Bone Morphogenetic Protein (rhBMP) - 2

      2. 5.1.2 Recombinant Human Bone Morphogenetic Protein (rhBMP) -7

    2. 5.2 Application

      1. 5.2.1 Spinal Fusion

      2. 5.2.2 Trauma

      3. 5.2.3 Reconstructive Surgery

      4. 5.2.4 Oral-maxillofacial

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle East & Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East & Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Johnson & Johnson

      2. 6.1.2 Ember therapeutics Inc.

      3. 6.1.3 Integra Lifesciences Holdings Corporation

      4. 6.1.4 Medtronic PLC

      5. 6.1.5 Bio-Techne (R&D Systems, Inc.)

      6. 6.1.6 Merck KGaA

      7. 6.1.7 Pfizer, Inc.

      8. 6.1.8 Stryker Corporation

      9. 6.1.9 Thermo Fischer Scientific

      10. 6.1.10 Zimmer Biomet Holdings, Inc.

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Bone Morphogenetic Protein Market market is studied from 2018 - 2026.

The Bone Morphogenetic Protein Market is growing at a CAGR of 2.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Medtronic plc., Stryker Corporation, Thermo Fischer Scientific, Merck KGaA, Johnson & Johnson are the major companies operating in Bone Morphogenetic Protein Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!